---
title: "Propanc Biopharma (PPCB.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/PPCB.US/norm.md"
symbol: "PPCB.US"
name: "Propanc Biopharma"
parent: "https://longbridge.com/zh-CN/quote/PPCB.US.md"
datetime: "2026-06-13T23:38:20.089Z"
locales:
  - [en](https://longbridge.com/en/quote/PPCB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PPCB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PPCB.US/norm.md)
---

# Propanc Biopharma (PPCB.US) — 财务报表

## 利润表 (USD)

| 指标 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -7.09 | -7.53 | -9.81 | -8.77 | -312.46 |
| ROE | -250.90% | -129.72% | -136.91% | -101.79% | -3104.30% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -6.36M | -4.02M | -4.84M | -4.07M | -54.07M |
| 营业利润 | -6.40M | -3.65M | -4.67M | -3.65M | -53.13M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 14.33M | 15.11M | 17.98M | 19.63M | 22.53M |
| 权益乘数 | 1.32 | 1.32 | 1.25 | 1.41 | 1.25 |
| 每股净资产 | 11.24 | 19.43 | 28.03 | 29.94 | 38.95 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 443702.00 | 561237.00 | 602737.00 | 12088.00 | 50760.00 |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 50805.00 | 55298.00 | 58643.00 | 59413.00 | 1661.00 |
| 净债务 | 130171.00 | 87979.00 | 92331.00 | 1.71M | 1.20M |

## 现金流量表 (USD)

| 指标 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -1.14M | -999140.00 | -1.94M | -27186.00 | -136196.00 |
| 投资现金流 | -154.00 | -2267.00 | -2491.00 | - | - |
| 融资现金流 | 981614.00 | 965099.00 | 2.53M | 7756.00 | 187485.00 |
| 自由现金流 | -4.71M | -1.17M | -68217.00 | 3.00M | -42.72M |
| 现金流充裕率 | -6162.06% | -44073.22% | -188.55% | -111.47% | -1702.45% |
| 举债与偿债 | 0.0000 | 0.0000 | 253249.00 | 296800.00 | 195485.00 |
| 资本支出 | -154.00 | -2267.00 | -2491.00 | - | - |